Credit Suisse Ag Argenx Se Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Argenx Se stock. As of the latest transaction made, Credit Suisse Ag holds 770 shares of ARGX stock, worth $483,806. This represents 0.0% of its overall portfolio holdings.

Number of Shares

770

Previous 770 -0.0%

Holding current value

$483,806

Previous $292,000 3.77%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$338.91 - $506.01 $16,945 - $25,300	-50 Reduced 6.1%	770 $292,000
Q3 2023 Nov 13, 2023	SELL	$369.35 - $548.43 $303,975 - $451,357	-823 Reduced 50.09%	820 $403,000
Q2 2023 Aug 11, 2023	BUY	$360.14 - $422.58 $212,842 - $249,744	591 Added 56.18%	1,643 $640,000
Q1 2023 May 10, 2023	SELL	$334.23 - $403.65 $65,843 - $79,519	-197 Reduced 15.77%	1,052 $391,000
Q4 2022 Feb 13, 2023	BUY	$342.17 - $402.31 $16,766 - $19,713	49 Added 4.08%	1,249 $473,000
Q2 2022 Aug 12, 2022	SELL	$269.58 - $378.88 $33.7 Million - $47.4 Million	-125,084 Reduced 99.05%	1,200 $455,000
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $6.22 Million - $8.58 Million	-24,433 Reduced 16.21%	126,284 $39.8 Million
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $15.8 Million - $20.5 Million	-57,978 Reduced 27.78%	150,717 $52.8 Million
Q3 2021 Nov 12, 2021	SELL	$295.0 - $350.58 $574,955 - $683,280	-1,949 Reduced 0.93%	208,695 $63 Million
Q2 2021 Aug 16, 2021	BUY	$257.11 - $319.92 $63,506 - $79,020	247 Added 0.12%	210,644 $63.4 Million
Q1 2021 May 14, 2021	BUY	$268.3 - $380.31 $31.1 Million - $44.1 Million	115,976 Added 122.83%	210,397 $57.9 Million
Q4 2020 Feb 12, 2021	SELL	$248.13 - $308.36 $22.1 Million - $27.4 Million	-88,980 Reduced 48.52%	94,421 $27.8 Million
Q3 2020 Nov 13, 2020	SELL	$215.51 - $272.51 $7.63 Million - $9.65 Million	-35,400 Reduced 16.18%	183,401 $48.1 Million
Q2 2020 Aug 12, 2020	SELL	$127.44 - $232.72 $8.93 Million - $16.3 Million	-70,035 Reduced 24.25%	218,801 $49.3 Million
Q1 2020 May 13, 2020	BUY	$108.83 - $165.23 $3.37 Million - $5.11 Million	30,956 Added 12.0%	288,836 $38 Million
Q4 2019 Feb 12, 2020	SELL	$106.59 - $164.21 $2.22 Million - $3.42 Million	-20,850 Reduced 7.48%	257,880 $41.4 Million
Q3 2019 Nov 12, 2019	BUY	$113.31 - $150.51 $2.08 Million - $2.77 Million	18,386 Added 7.06%	278,730 $31.8 Million
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $11.4 Million - $14 Million	99,159 Added 61.52%	260,344 $36.9 Million
Q1 2019 May 14, 2019	BUY	$98.85 - $134.59 $15.9 Million - $21.7 Million	161,185 New	161,185 $20.1 Million
Q3 2018 Nov 13, 2018	SELL	$75.5 - $96.63 $202,113 - $258,678	-2,677 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$74.84 - $100.16 $200,346 - $268,128	2,677 New	2,677 $222,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account